Ryan Crowe
Senior Vice President of Investor Relations
Replay available
Regeneron Pharmaceuticals, Inc. (REGN) Q3 2025 Earnings Call
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Q3 2025 earnings conference call, held 2025-10-28. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Leonard S. Schleifer
Board Co-Chair, Co-Founder, President and Chief Executive Officer
Dr. George D. Yancopoulos
Board Co-Chair, Co-Founder, President and Chief Scientific Officer
Marion McCord
Executive Vice President of Commercial
Chris Fenimore
Executive Vice President and Chief Financial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Regeneron Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.899 Welcome to the Regeneron Pharmaceuticals Third Quarter 2025 Earnings Conference Call. 00:00:04.899 -- 00:00:08.264 My name is Shannon, and I will be your operator for today's call. 00:00:08.264 -- 00:00:11.369 At this time, all participants are in a listen-only mode. 00:00:11.369 -- 00:00:13.833 Later, we will conduct a question and answer session. 00:00:13.833 -- 00:00:16.377 Please note that this conference is being recorded. 00:00:16.377 -- 00:00:20.143 I will now turn the call over to Ryan Crowe, Senior Vice President of Best Relations. 00:00:20.143 -- 00:00:20.784 You may begin. 00:00:20.784 -- 00:00:22.784 Thank 00:00:23.048 -- 00:00:26.553 you, Shannon. Good morning, good afternoon, and good evening to everyone listening around 00:00:26.553 -- 00:00:29.682 the world. Thank you for your interest in Regeneron, and welcome to our third quarter 00:00:29.682 -- 00:00:34.667 2025 earnings conference call. An archive and transcript of this call will be available 00:00:34.667 -- 00:00:39.111 on the Regeneron Investor Relations website shortly after our call concludes. 00:00:39.111 -- 00:00:44.256 Joining me on today's call are Dr. Leonard Schleifer, Board Co-Chair, Co-Founder, President, 00:00:44.256 -- 00:00:49.641 and Chief Executive Officer, Dr. George Yancopoulos, Board Co-Chair, Co-Founder, President, 00:00:49.641 -- 00:00:54.352 and Chief Scientific Officer, Marion McCord, Executive Vice President of Commercial, 00:00:54.352 -- 00:00:58.899 and Chris Fenimore, Executive Vice President and Chief Financial Officer. 00:00:58.899 -- 00:01:03.567 After our prepared remarks, the remaining time will be available for Q&A. 00:01:03.567 -- 00:01:06.772 I would like to remind you that remarks made on today's call may include forward-look...